According to Albert Camus, “Nobody realizes that some people expend tremendous energy merely to be normal.” The transition from patient under active treatment to being just an everyday cancer survivor can be a most challenging experience for many of us. Our surgical scars and the radiation burns have subsided and those that remain are [...]
We all know about the terror that has struck Boston. Two bombs exploded near at the finish line of the Boston Marathon, killing three people and seriously injuring over 150 other individuals! One of the dead was an eight-year-old child. I know when I heard about the death of the child I prayed that this [...]
Currently as our advanced prostate cancer progresses and we develop bone and soft tissue tumors our pain increases significantly. Current treatment options for the palliation of this pain includes painkillers (including opioids and methadone), radiation and in rare incidents surgery. All of these options have significant limitations. Drugs eventually become less effective, especially for breakout [...]
More on Sipuleucel-T (Provenge) from the 2013 The last two abstracts that I want to speak about that were presented at the conference that pertained to Provenge speak to its efficacy. The first looks at changes in circulating tumor cells (CTC) and the second to the onset of the use of opioid painkillers. Abstract #40 [...]
Radium-223 Chloride (Alpharadin) is now available for the treatment of men with advanced prostate cancer who have symptomatic bone metastases (painful) and who are also castration-resistant (hormone-refractory). This is an expanded access program that will allow the use of Alpharadin prior to the formal FDA approval of the treatment. From the Clinical Trials Web Page [...]